AMGN vs BCPC · P/E 24, rev $10.05B vs P/E 39, rev $554.7M
Amgen Inc (AMGN) versus Balchem Corporation (BCPC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Balchem Corporation (BCPC) is a specialty chemicals company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BCPC revenue for 2026-06-30 was $554.7M. Net income was $84.9M. BCPC currently screens at market cap $5.38B and trailing P/E 39.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BCPC currently screens at market cap $5.38B and trailing P/E 39.5.
Not investment advice. Open the AMGN and BCPC stock pages for the full models.
Not investment advice.